Clinical implications of the serum CA19-9 level in “biological borderline resectability” and “biological downstaging” in the setting of preoperative chemoradiation therapy for pancreatic cancer

Autor: Takahashi, Hidenori, Yamada, Daisaku, Asukai, Kei, Wada, Hiroshi, Hasegawa, Shinichiro, Hara, Hisashi, Shinno, Naoki, Ushigome, Hajime, Haraguchi, Naotsugu, Sugimura, Keijiro, Yamamoto, Kazuyoshi, Nishimura, Junichi, Yasui, Masayoshi, Omori, Takeshi, Miyata, Hiroshi, Ohue, Masayuki, Yano, Masahiko, Sakon, Masato, Ishikawa, Osamu
Zdroj: In Pancreatology July 2020 20(5):919-928
Databáze: ScienceDirect